EUVIMEDOpdag EUVIMED
EUVIMED · CrossrefJournal

Clinical Cancer Research

ISSN 1078-0432 · American Association for Cancer Research (AACR)

Latest articles

  1. A randomised phase II trial of neoadjuvant chemotherapy with or without concurrent aromatase inhibitor therapy in ER-positive breast cancer (ANZ1401 ELIMINATE)

    Nicholas Murray, Luis E. Lara Gonzalez, Nicholas Wilcken, Andrew D. Redfern, Frances M. Boyle, Andrew J. Spillane, Nicholas Zdenkowski, Val Gebski, Nuria Chic Ruché, Franco Caramia, Cameron E. Snell, Courtney T. Van Geelen, Jasmine Kay, Rebecca Asher, Clair L. Shadbolt, Susan Tiley, Janine Lombard, Wendy A. Raymond, Benjamin Dessauvagie, Heath Badger, Sherene Loi, Prudence A. Francis

    Published: 2026-11-20DOI: 10.1158/1078-0432.ccr-26-0501

  2. The first-in-class SFK ‘OFF’ inhibitor NXP900 suppresses YAP signaling and demonstrates tumor growth suppression in cholangiocarcinoma

    Hendrien Kuipers, Danielle M. Carlson, Erik Jessen, Aushinie M. Abeynayake, Jack W. Sample, Enis H. Ozmert, Dong-Gi Mun, Jennifer L. Tomlinson, Amro M. Abdelrahman, Nathan W. Werneburg, Binbin Li, Meina Cai, Caitlin B. Conboy, Mitesh J. Borad, Mark J. Truty, Akhilesh Pandey, Sumera I. Ilyas, Gregory J. Gores, Rory L. Smoot

    Published: 2026-11-20DOI: 10.1158/1078-0432.ccr-26-0849

  3. Serplulimab combined with nab-paclitaxel and epirubicin in high-risk, early HR+/HER2- breast cancer (HELEN-B 018): a multicentre, single-arm, phase 2 trial

    Hao Dai, Zhenduo Lu, Xianfu Sun, Ya Wei, Chengzheng Wang, Haiquan Jia, Junzhao Wu, Xiuchun Chen, Jianghua Qiao, Chongjian Zhang, Lianfang Li, Jifeng Yu, Ping Li, Peng Yuan, Xuhui Guo, Yadong Sun, Ping Lu, Xin Wang, Dechuang Jiao, Jiujun Zhu, Jiao Zhang, Juntao Li, Tao Huang, Tian Xie, Lei Hou, Lina Wang, Yajie Zhao, Jia Wang, Xilong Gong, Xin Zhao, Lianjie Niu, Qingxin Xia, Zhenzhen Liu

    Published: 2026-11-20DOI: 10.1158/1078-0432.ccr-26-1735

  4. Molecular Residual Disease After Definitive Chemoradiotherapy in Locally Advanced Head and Neck Cancer: Clinical Value and Optimal Timing for ctDNA Assessment.

    Gema Bruixola, Jorge Martín-Arana, Francisco Gimeno-Valiente, Franz Villarroel-Espindola, Clara Alfaro-Cervelló, Delfina Dualde, Nuria Grimalt, Miguel García Bartolomé, Alonso García-Márquez, Belén Iglesias-Martinez, Francisco Martínez-Picó, Belén Martínez-Castedo, Blanca García-Micó, Daniel González. Camblor, Maria Eugenia Iglesias, Vicente Escorihuela García, María Maroñas, Jim Hayes, Andrés Cervantes, Noelia Tarazona

    Published: 2026-11-17DOI: 10.1158/1078-0432.ccr-26-1545

  5. Longitudinal Detection of Circulating Tumor DNA in Children with Pleuropulmonary Blastoma: A Report from the International PPB/DICER1 Registry

    Kris Ann P. Schultz, Amanda L. Field, Paige H.R. Mallinger, Chenyu Xu, Benjamin Deonovic, Alexander T. Nelson, Dave Watson, Kelly Hagedorn, Damon R. Olson, Junne Kamihara, Kenneth S. Chen, Sarah G. Mitchell, David B. Wilson, Christina E. Amend, William Mize, Yan Su, Chao Duan, Zhixia Yue, Chao Gao, Kelly Klega, Louis P. Dehner, Yoav H. Messinger, Brian D. Crompton, Anne K. Harris, D. Ashley Hill

    Published: 2026-11-17DOI: 10.1158/1078-0432.ccr-26-1981

  6. Identification of Proteomic Subtypes with Differential Responses to Immune Checkpoint Inhibition in Cutaneous Melanoma

    Shrabanti Chowdhury, Kourosh Abdollahi, Francesca Petralia, Jacob J. Kennedy, Jianhui Gong, Weiping Ma, Richard G. Ivey, Rose C. Pletcher, Azra Krek, Ata S. Moshiri, Zachary T. Herbert, Travis D. Lorentzen, Yan-Chak Li, Yi Hsiao, Anna Xing, Nicole Tignor, Jeffrey R. Whiteaker, Antonella Bacchiocchi, Mehdi Mesri, Jeffrey E. Gershenwald, Victor G. Prieto, Alexander J. Lazar, Ryan J. Sullivan, Genevieve M. Boland, Tara C. Mitchell, Giorgos Karakousis, Douglas B. Johnson, Ruth Halaban, Georgina V. Long, Richard A. Scolyer, Iman Osman, Paul W. Harms, Kelly L. Harms, Charlotte E. Ariyan, Piotr Rutkowski, Anna M. Czarnecka, Anna Szumera-Ciećkiewicz, Dirk Schadendorf, Anne Zaremba, Marcus Bosenberg

    Published: 2026-11-17DOI: 10.1158/1078-0432.ccr-26-2295

  7. Molecular Features Underlying Discordance Between Clinical and Genomic Risk Stratification in Localized Prostate Cancer in Over 280, 000 Patients

    Michael J. Zelefsky, Hyunnam Ryu, Xin Zhao, Qi Joslove. Xu, Mohammed Alshalalfa, Yang Liu, Marla Johnson, Elai Davicioni, James A. Proudfoot, Tyler M. Seibert, Sarah Howlett, Gerhardt Attard, Melvin L.K. Chua, Edward M. Schaeffer, Adam B. Weiner, Matthew R. Cooperberg, Ashley E. Ross, Krishnan R. Patel, Phuoc Tran, Himanshu Nagar, Michael Leapman, David Wise, Daniel E. Spratt, Angela Y. Jia

    Published: 2026-11-17DOI: 10.1158/1078-0432.ccr-26-2348

  8. Spatial Immune Organization Associates with Response to CD40 Agonism in BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer: A Phase I Trial

    Juan C. Osorio, Lucas Blanchard, Ning Yao, Syed M. Alam, Ali Ghasemzadeh, Steven Grudman, Karissa Whiting, Venkatraman E. Seshan, Andrew Mijacika, Carlo Sevilla, Juan C. Angulo-Lozano, Ved P. Sharma, Morgan Tomberlin, Melissa McCarter, Jessica Pfau, Jeffrey L. Wong, David A. Knorr, Timothy F. Donahue, Robert Smith, Eugene J. Pietzak, Benjamin Greenbaum, Hikmat Al-Ahmadie, Jonathan E. Rosenberg, Jeffrey V. Ravetch, Bernard Bochner

    Published: 2026-11-17DOI: 10.1158/1078-0432.ccr-26-3256

  9. Molecular and Clinical Characteristics of Patients with Non–Small Cell Lung Cancer Harboring KRAS Q61 Mutations to Assess Therapeutic Responses

    Lea Ruge, Felix John, Malte Verheyen, Richard Riedel, Sebastian Michels, Lucia Nogova, Heather Scharpenseel, Rieke Fischer, Sofia Stilianakis, Janna Siemanowski-Hrach, Jana Fassunke, Anna Rasokat, Anna Kron, Marvin Kirsch, Monika Serke, Jutta Kappes, Kato Kambartel, Udo Siebolts, Sabine Merkelbach-Bruse, Reinhard Büttner, Jürgen Wolf, Matthias Scheffler

    Published: 2026-11-16DOI: 10.1158/1078-0432.ccr-26-0133

  10. Second- and Third-Line Outcomes after Selective RET Inhibitor Failure in RET Fusion-Positive Metastatic Lung Cancer: A Real-World Analysis from the RET-MAP Registry

    Daniela Miliziano, Julia K. Rotow, Meghanne Lomibao, Arianna Marinello, Helena Bote-de Cabo, Fabrizio Citarella, Lorenza Landi, Massimiliano Cani, Mariana Brandão, Jamie Feng, Sophie Cousin, Andrea De Giglio, Marco Tagliamento, Philippe Rochigneux, Florian Guisier, Lea Ruge, Annarita Avanzo, Francesca Colamartini, Francesco Cortiula, Vladmir Cordeiro de Lima, Antonio Calles, Patricia Iranzo, Barliz Waissengrin, Clarisse Audigier-Valette, Frank Aboubakar, Noemie Simon-Tillaux, Vinicius Ernani, Jordi Remon, Alessio Cortellini, David Planchard, Biagio Ricciuti, Benjamin Besse, Petros Christopoulos, Alexander Drilon, Mihaela Aldea

    Published: 2026-11-12DOI: 10.1158/1078-0432.ccr-26-2942

  11. Targeting DHFR to suppress one-carbon metabolism and enhance radiation sensitivity in patients with NRF2-active head and neck squamous cell carcinoma

    Paul Zolkind, Emily M. Wilkerson, Harit Panda, Julius Chembo, James Sun, Kate Zhao, Jessica Ley, Michael Atteberry, Kevin Cho, Nathan T. Wamsley, Dennis Goldfarb, Kynlee G. Giesie, Joe C. Major, Xiaoxin Chen, Ryan S. Jackson, Jason T. Rich, Patrik Pipkorn, R. Alex Harbison, Ben Wahle, Anthony J. Apicelli, Jennifer De Los Santos, Wade L. Thorstad, Gary J. Patti, Sidharth V. Puram, Peter Oppelt, Doug Adkins, Michael B. Major

    Published: 2026-11-11DOI: 10.1158/1078-0432.ccr-26-0700

  12. SPROUT Guidelines for Molecular Profiling for Children with Solid Tumors: A Consensus Recommendation from the American Association for Cancer Research

    Catherine Gestrich, Larissa V. Furtado, Jaclyn Biegel, Maryam Fouladi, Andrew L. Kung, Theodore W. Laetsch, Sarah Leary, Marilyn M. Li, Elaine Mardis, David Malkin, Alberto S. Pappo, Donald W. Parsons, Angshumoy Roy, Erin Rudzinski, Jack F. Shern, Adam Shlien, Neerav Shukla, Katherine A. Janeway, Alanna J. Church

    Published: 2026-11-11DOI: 10.1158/1078-0432.ccr-26-1643

  13. Anti-TNFR2 Antibody BI-1808 Induces Tumor Regression and Antitumor T-cell Immunity through Treg and Myeloid Cell Modulation in Patients with Solid Tumors

    Ingrid Teige, Kristoffer S. Rohrberg, Ana Carneiro, Jeffrey Yachnin, Susanne Gertsson, Petra Holmkvist, Linda Mårtensson, Rikke L. Eefsen, Zsuzsanna Pápai, István Láng, Harriet Walter, Marie Borggren, Marica Vaapil, Jan Anders Nilsson, Carolin Svensson, Mathilda Kovacek, Therese Blidberg, Kirstie Cleary, Robert J. Oldham, Alexandra Gabriela Ferreira, Benjamin L. Duell, Anette Sundstedt, Niyaz Yoosuf, Monika Semmrich, Danijela Lindahl, Stephen A. Beers, Sean H. Lim, Johan Wallin, Ingrid Karlsson, Mark S. Cragg, Björn Frendéus, Andres McAllister

    Published: 2026-11-11DOI: 10.1158/1078-0432.ccr-26-2049

  14. Phase I Trial and Biomarker Analysis of Buparlisib with Weekly Cisplatin and Radiotherapy in High-risk Locally Advanced Squamous Cell Cancer of the Head and Neck

    Jochen H. Lorch, Kristine Wong, Roy B. Tishler, Robert I. Haddad, Anne O’Neill, Kee-Young Shin, Mofei Liu, Glenn J. Hanna, Nicole G. Chau, Guilherme Rabinowits, Jonathan D. Schoenfeld, Danielle N. Margalit, Laura Goguen, Ravindra Uppaluri, Tom Thomas, Alec Kacew, Patricia McHugh, Ethan Harris, Kimberly Austin, Julian Huang, Umair Mahmood, Bose S. Kochupurakkal, Lynette M. Sholl, Jennifer M. Spangle

    Published: 2026-11-06DOI: 10.1158/1078-0432.ccr-21-3677

Volumes

2026 · 2,7422025 · 6392024 · 5832023 · 5722022 · 6042021 · 1,1122020 · 1,4062019 · 9782018 · 1,1732017 · 1,1952016 · 1,0802015 · 1,0712014 · 7922013 · 9392012 · 1,0042011 · 8552010 · 1,0532009 · 9842008 · 1,0922007 · 1,0312006 · 1,0512005 · 1,1732004 · 1,118

Viden, der passer til dit arbejde.

Fra en gratis start over personlig litteratursøgning til den komplette Research Suite.

Se priser →

Er alle forlagsfuldtekster inkluderet?

Nej. Bibliografiske referencer, abstracts og fuldtekster er forskellige typer indhold. Om en fuldtekst er tilgængelig, afhænger af kilden, Open Access og dine eksisterende licenser. Et EUVIMED-abonnement erstatter ikke yderligere forlagsrettigheder.